The E3 ubiquitin ligases involved in TAK1 signaling and regulation of NAFLD are TRIM31, TRIM16, TRIM8, TRAF6, and TRAF3, and the DUBs are USP4, USP18, USP13, and CYLD (Figure 1). This evidence concerns the gene CYLD and metabolic dysfunction-associated steatotic liver disease.